| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.907 | 11.628 | 14.538 | 15.049 | 14.944 | 12.516 | 15.720 | 10.920 | 6.277 | 5.317 |
| Total Income - EUR | 3.907 | 11.628 | 14.538 | 15.049 | 14.946 | 12.516 | 15.721 | 10.921 | 6.278 | 5.320 |
| Total Expenses - EUR | 2.843 | 9.883 | 9.051 | 11.433 | 6.893 | 8.878 | 7.459 | 10.878 | 8.390 | 7.151 |
| Gross Profit/Loss - EUR | 1.065 | 1.745 | 5.488 | 3.616 | 8.053 | 3.638 | 8.262 | 42 | -2.111 | -1.830 |
| Net Profit/Loss - EUR | 947 | 1.396 | 5.052 | 3.164 | 7.605 | 3.289 | 7.790 | -236 | -2.113 | -1.839 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Histoclinic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.262 | 3.430 | 11.558 | 14.541 | 7.870 | 10.972 | 12.277 | 11.920 | 10.944 | 7.876 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 81 | 0 | 0 | 0 |
| Receivables | 670 | 1.534 | 5.748 | 2.872 | 2.746 | 3.677 | 4.837 | 3.417 | 4.189 | 4.218 |
| Cash | 1.591 | 1.896 | 5.811 | 11.669 | 5.124 | 7.295 | 7.360 | 8.503 | 6.755 | 3.658 |
| Shareholders Funds | 1.990 | 3.366 | 8.360 | 11.371 | 7.655 | 10.799 | 12.007 | 11.808 | 9.659 | 7.767 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 81 | 81 | 81 | 80 |
| Debts | 272 | 65 | 3.198 | 3.170 | 215 | 173 | 270 | 112 | 1.324 | 109 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Histoclinic Srl